A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinomaAhmed Bilal Khalid, Shadia I. Jalal, Heather Burney et al.|Frontiers in Oncology|2024Cited by 4